Analytical Data
-
Gene name
C1orf33
- Application
-
Alternative Names
MRTO4; C1orf33; MRT4; mRNA turnover Protein 4 homolog; Ribosome assembly factor MRTO4
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9UKD2
-
Expression Region
1-239aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSMPKSKRD KKVSLTKTAK KGLELKQNLI EELRKCVDTY KYLFIFSVAN MRNSKLKDIR NAWKHSRMFF GKNKVMMVAL GRSPSDEYKD NLHQVSKRLR GEVGLLFTNR TKEEVNEWFT KYTEMDYARA GNKAAFTVSL DPGPLEQFPH SMEPQLRQLG LPTALKRGVV TLLSDYEVCK EGDVLTPEQA RVLKLFGYEM AEFKVTIKYM WDSQSGRFQQ MGDDLPESAS ESTEESDSED DD
-
Molecular Weight
30 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
C1orf33, also known as Chromosome 1 Open Reading Frame 33, has emerged as a protein of interest in various biological research contexts due to its potential roles in cellular processes and disease mechanisms. Initially identified through genomic analyses, this protein is located on chromosome 1 and is believed to be involved in critical pathways related to cell signaling and immune responses. Recent studies have suggested that C1orf33 may play a role in modulating inflammatory responses and could be linked to autoimmune diseases and certain types of cancer. Researchers have begun to focus on characterizing the protein’s structure and function, aiming to elucidate its mechanistic pathways and interactions with other cellular components. Recombinant C1orf33 protein has been expressed and purified to facilitate in-depth studies, including its effects on cellular behavior and its potential as a therapeutic target. This research not only aims to clarify the biological significance of C1orf33 but also to explore its application in diagnostics and treatment strategies, particularly in conditions where its regulatory functions are compromised. The ongoing investigation into C1orf33 represents a promising frontier in molecular biology and therapeutic development, with implications for improving understanding and management of related diseases.
